Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG positive patients.
Neuhaus
P
P
Department of Surgery, Universitätsklinikum Rudolf Virchow, Free University of Berlin, Germany.
Steffen
R
R
Blumhardt
G
G
Bechstein
W
W
Keck
H
H
Lemmens
H P
HP
Neuhaus
R
R
Lobeck
H
H
König
V
V
Hopf
U
U
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D004279:DNA, Viral / Q000032:analysis; D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006515:Hepatitis B virus / Q000032:analysis; D006801:Humans; D007116:Immunization, Passive; D007370:Interferon Type I / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D011994:Recombinant Proteins; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood
D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D007370:Interferon Type I; D011994:Recombinant Proteins; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase